Market Closed -
Nasdaq
04:00:00 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
2.22
USD
|
+0.91%
|
|
-.--%
|
+35.37%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
415.5
|
553.8
|
1,502
|
670
|
565.9
|
797.2
|
-
|
Enterprise Value (EV)
1 |
565
|
488.1
|
922.6
|
512.4
|
565.9
|
797.2
|
797.2
|
P/E ratio
|
-1.23
x
|
-0.55
x
|
-6.09
x
|
-1.94
x
|
-3.24
x
|
-303
x
|
303
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.48
x
|
9.09
x
|
26.8
x
|
0.94
x
|
0.62
x
|
0.85
x
|
0.79
x
|
EV / Revenue
|
5.48
x
|
9.09
x
|
26.8
x
|
0.94
x
|
0.62
x
|
0.85
x
|
0.79
x
|
EV / EBITDA
|
-12,362,651
x
|
-21,647,613
x
|
46,816,624
x
|
-42,404,415
x
|
19,375,914
x
|
-
|
-
|
EV / FCF
|
-1.27
x
|
-9.15
x
|
-9.43
x
|
-38.6
x
|
-19.6
x
|
-403
x
|
-82.2
x
|
FCF Yield
|
-78.9%
|
-10.9%
|
-10.6%
|
-2.59%
|
-5.09%
|
-0.25%
|
-1.22%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
10,629
|
91,900
|
205,599
|
236,600
|
260,490
|
263,191
|
-
|
Reference price
2 |
39.09
|
6.026
|
7.306
|
2.832
|
2.172
|
3.029
|
3.029
|
Announcement Date
|
3/30/20
|
3/18/21
|
4/27/22
|
4/24/23
|
3/21/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
75.86
|
60.92
|
56.13
|
712.2
|
909
|
943.1
|
1,011
|
EBITDA
|
-33.61
|
-25.58
|
32.09
|
-15.8
|
29.2
|
-
|
-
|
EBIT
1 |
-78.8
|
-185.4
|
-132.1
|
-347.8
|
-162.8
|
5.078
|
10.8
|
Operating Margin
|
-103.87%
|
-304.35%
|
-235.41%
|
-48.83%
|
-17.91%
|
0.54%
|
1.07%
|
Earnings before Tax (EBT)
|
-276.3
|
-206.3
|
-232.5
|
-379.8
|
-
|
-
|
-
|
Net income
1 |
-271.5
|
-239.7
|
-230.4
|
-335.1
|
-172.7
|
-4
|
3.9
|
Net margin
|
-357.85%
|
-393.45%
|
-410.46%
|
-47.05%
|
-18.99%
|
-0.42%
|
0.39%
|
EPS
2 |
-31.70
|
-11.00
|
-1.200
|
-1.460
|
-0.6700
|
-0.0100
|
0.0100
|
Free Cash Flow
1 |
-327.9
|
-60.52
|
-159.2
|
-17.38
|
-28.81
|
-1.978
|
-9.7
|
FCF margin
|
-432.24%
|
-99.35%
|
-283.69%
|
-2.44%
|
-3.17%
|
-0.21%
|
-0.96%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/30/20
|
3/18/21
|
4/27/22
|
4/24/23
|
3/21/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
22.72
|
17.6
|
223.7
|
230.5
|
240.4
|
202.5
|
-
|
248.4
|
197.8
|
240.4
|
245.1
|
258.2
|
215.2
|
257.9
|
EBITDA
|
18.42
|
-0.675
|
-25.93
|
18.32
|
-7.549
|
7.415
|
-
|
3.479
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-44
|
-23.17
|
-81.42
|
-88.54
|
-154.6
|
-29.68
|
-
|
-84.94
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-193.67%
|
-131.67%
|
-36.4%
|
-38.41%
|
-64.33%
|
-14.66%
|
-
|
-34.19%
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-46.97
|
-38.04
|
-75.76
|
-105.8
|
-160.2
|
-34.78
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-54.99
|
-37.9
|
-73.3
|
-98.11
|
-125.8
|
-34.2
|
-21.78
|
-82.79
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-242.04%
|
-215.4%
|
-32.77%
|
-42.56%
|
-52.33%
|
-16.89%
|
-
|
-33.32%
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.3000
|
-0.2000
|
-0.3100
|
-0.4100
|
-0.5400
|
-0.1400
|
-0.0800
|
-0.3200
|
-0.0100
|
-
|
-
|
0.0100
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/27/22
|
5/16/22
|
8/12/22
|
11/14/22
|
4/24/23
|
5/15/23
|
11/13/23
|
3/21/24
|
5/9/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
150
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
65.7
|
580
|
158
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-4.449
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-328
|
-60.5
|
-159
|
-17.4
|
-28.8
|
-1.98
|
-9.7
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
138
|
3.02
|
3.79
|
10.7
|
7.85
|
10.3
|
12.3
|
Capex / Sales
|
182.09%
|
4.96%
|
6.76%
|
1.5%
|
0.86%
|
1.09%
|
1.22%
|
Announcement Date
|
3/30/20
|
3/18/21
|
4/27/22
|
4/24/23
|
3/21/24
|
-
|
-
|
Last Close Price
3.029
CAD Average target price
4.957
CAD Spread / Average Target +63.66% Consensus |
1st Jan change
|
Capi.
|
---|
| +35.37% | 584M | | +40.73% | 739B | | +32.83% | 598B | | -6.30% | 353B | | +15.15% | 318B | | +4.05% | 285B | | +15.00% | 240B | | -5.52% | 206B | | +6.17% | 164B | | -0.45% | 162B |
Other Pharmaceuticals
|